AXA Framlington Health R Acc
Category Sector Equity Healthcare
Last buy/sell price
2,933.00p
-51.00p (-1.71%)
Fund Code
0350642
GB0003506424
Prices updated as at 31 Mar 2025
|
Prices in GBX
Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Fund status | Open |
Fund type | Unit Trust |
Fund manager | Chris Eccles, Cinney Zhang, Catherine Tennyson |
3442 | |
2933 | |
Fund comparative index | MSCI World/Health Care NR GBP |
Healthcare | |
- | |
1.57 | |
0.08 | |
- | |
Sector Equity Healthcare | |
No | |
Fund provider | AXA Investment Managers UK Ltd |
Share class launch date | 16 Oct 1991 |
£518.28m | |
- | |
- | |
- | |
Semi-Annually |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.